Explore >> Select a destination

You are here

 news.mcmaster.ca
Researchers to begin human trials for promising new inhaled COVID-19 vaccines designed to combat variants of concern - McMaster News
| | www.fda.gov
FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants | FDA
1.8 parsecs away

Travel
| | The FDA amended the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. The updated vaccine addresses currently circulating variants to provide better protection against serious consequences of COV
| | www.the-scientist.com
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic | The Scientist Magazine®
2.6 parsecs away

Travel
| | Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients' cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down?
| | brighterworld.mcmaster.ca
Researchers to begin human trials for promising new inhaled COVID-19 vaccines designed to combat variants of concern - Brighter World
0.0 parsecs away

Travel
| | Update, March 3, 2022: Human clinical trials for these vaccines have begun and are ongoing. This story was originally published on Dec. 7, 2021. Human . . .
| | www.epa.gov
Chemicals, Pesticides and Toxics Topics | US EPA
14.3 parsecs away

Travel
| Learn how to safely handle chemicals, the effects of certain toxins, which substances are controlled or managed, and safer alternatives.